Validation of the Turkish Version of the Pain Sensitivity Questionnaire

Overview

The Pain Sensitivity Questionnaire(PSQ) is a self-rating measure for the assessment of pain sensitivity and has been developed by Dr. R. Ruscheweyh in Germany. It consists of 17 items rated from 0, not at all painful to 10, most severe pain imaginable. The validation of the Turkish version of PSQ is needed, in order to measure pain sensitivity among Turkish people.

Full Title of Study: “Validation of the Turkish Version of the Pain Sensitivity Questionnaire in Patients With Chronic Pain”

Study Type

  • Study Type: Observational [Patient Registry]
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 15, 2018

Clinical Trial Outcome Measures

Primary Measures

  • Measurement of pain intensity in Turkish people using The Turkish version of the PSQ
    • Time Frame: 1 day
    • Measurement of pain intensity in Turkish people using The Turkish version of the PSQ, consisting of 17 items, describing different daily life situations with a scoring from 0(not painful) to 10 (worst pain imaginable) on a numeric rating scale. A PSQ total score is between 0-10, the higher score, the more patient’s pain sensitivity.
  • Pain Catastrophizing Scale
    • Time Frame: 1 day
    • This scale is used in order to assess the state of mind of patients in pain through a comprehensive evaluation instrument that encompasses the different perspectives on catastrophizing. It is a self-report measure, consisting of 13 items scored from 0 to 4, resulting in a total possible score of 52.24 The higher the score, the more catastrophizing thoughts are present.
  • Beck Anxiety Inventory
    • Time Frame: 1 day
    • This scale, consisting of 21 items, is a self-report measure of anxiety. Score of 0-21 shows low anxiety. Score of 22-35 shows moderate anxiety. Score of 36 and above shows potentially concerning levels of anxiety.

Participating in This Clinical Trial

Inclusion Criteria

  • ASA 1-2 – adult chronic low back pain patients having pain for greater than 3 months Exclusion Criteria:

  • Failed back surgery syndrome, – Morbid obesity (body mass index, >40), – Being a non-Turkish speaker, – Substance abuse disorder, – Major psychiatric disorder (eg, severe depression, bipolar disorder, Axis II personality disorder, and schizophrenia).

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 70 Years

Investigator Details

  • Lead Sponsor
    • Istanbul Medeniyet University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ferda Yilmaz Inal, Assistant Professor – Istanbul Medeniyet University
  • Overall Contact(s)
    • ferda yılmaz inal, 00905058207650, ferdayilmazinal@hotmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.